In addition they addressed the mice with JHU083 and an anti-PD-one checkpoint inhibitor, a form of immunotherapy drug that removes restraints most cancers cells position on immune cells. “To begin with, we believed we would need to use The 2 therapies sequentially as a way to stay away from any possible impact with the metabolic therapy within th